PHARMATHENE
PharmAthene, Inc., a biodefense company, develops medical countermeasures to prevent and treat morbidity and mortality associated with the use of biological and chemical weapons in the United States. Its products, which are under development, include Valortim, a prophylactic and therapeutic anti-anthrax monoclonal antibody; and Protexia, a recombinant form of human butyrylcholinesterase for clinical use in the treatment of organophosphate intoxication due to exposure to chemical nerve agents. The company was founded in 2001 and is headquartered in Annapolis, Maryland.
PHARMATHENE
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Annapolis, Maryland, United States
Country:
United States
Website Url:
http://www.pharmathene.com
Total Employee:
51+
Status:
Active
Contact:
4102692601
Total Funding:
84.3 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Network Solutions DNS Ruby On Rails Phusion Passenger Akamai Hosted Verizon
Similar Organizations
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Advisors List
Board_member
Board_member
2004-10-01
Board_member
2004-10-01
Current Employees Featured
John Gill Director, President & Chief Executive Officer @ PharmAthene
Director, President & Chief Executive Officer
Stock Details
Investors List
MPM Capital
MPM Capital investment in Post-IPO Secondary - PharmAthene
HealthCare Ventures
HealthCare Ventures investment in Post-IPO Secondary - PharmAthene
Ontario Teachers' Pension Plan
Ontario Teachers' Pension Plan investment in Post-IPO Secondary - PharmAthene
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Post-IPO Secondary - PharmAthene
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Post-IPO Equity - PharmAthene
Ontario Teachers' Pension Plan
Ontario Teachers' Pension Plan investment in Post-IPO Equity - PharmAthene
MDS
MDS investment in Post-IPO Equity - PharmAthene
MPM Capital
MPM Capital investment in Series B - PharmAthene
HealthCare Ventures
HealthCare Ventures investment in Series B - PharmAthene
Bear Stearns Health Innoventures L.P
Bear Stearns Health Innoventures L.P investment in Series B - PharmAthene
Official Site Inspections
http://www.pharmathene.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PharmAthene"
Company Profile - Pharmathen
Pharmathen proudly employs more than 1.500 people from over 24 different nationalities, with 52% of its total workforce being female and 73% of Pharmathen's Research Operations Team also being women. The company's …See details»
Our Leaders - Pharmathen
Pharmathen is a research-centered, pharmaceutical company which focuses in developing innovative generic products. ... Qualified Person appointed by the National Organization for …See details»
Pharmathen - Crunchbase Company Profile & Funding
Pharmathen is a private pharmaceutical company developing generic drugs. The company is focused on the development and marketing of pharmaceuticals, with a strong position in …See details»
Pharmathen SA - Drug pipelines, Patents, Clinical trials - Synapse
Pharmathen SA is a pharmaceutical company that specializes in the development, production, and marketing of various medications. ... The statistics for drugs in the Pipeline is the current …See details»
Pharmathen - LinkedIn
Pharmathen | 42,900 followers on LinkedIn. Innovation inspired by life | Founded in 1969, Pharmathen has become one of the largest, vertically integrated developers of complex drug …See details»
Pharmathen | Company Profile | Pharmacompass.com
Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary …See details»
Pharmathen Information - RocketReach
Pharmathen proudly employs more than 1,600 people from over 28 different nationalities, with 54% of its total workforce and 66% of its Research Operations Team being female. The …See details»
PHARMATHEN S.A Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PHARMATHEN S.A of Chennai, Tamil Nadu. Get the latest business insights from Dun & …See details»
Business Models - Pharmathen
Pharmathen is a research-centered, pharmaceutical company which focuses in developing innovative generic products. Pharmathen is providing a complete package of integrated …See details»
Pharmathen Company Profile - Craft
Pharmathen Summary. Company Summary. Overview. Pharmathen is a pharmaceutical company engaged in the research, development, and distribution of drugs. It specializes in the …See details»
Pharmathen - PharmaSource
Pharmathen is a research-centred pharmaceutical company that develops complex drug delivery and formulations to enhance patient compliance while providing affordable, high-quality …See details»
Pharmathen SA DMF, CEP, Written Confirmations, FDF
Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle management …See details»
Pharmathen - Contacts, Employees, Board Members, Advisors
Pharmathen is a private pharmaceutical company developing generic drugs. Senior Vice President, Business Development and Portfolio ManagementSee details»
Our Innovative DNA - Pharmathen
Pharmathen is a research-centered, pharmaceutical company which focuses in developing innovative generic products. Pharmathen is providing a complete package of integrated …See details»
PharmAthene - Crunchbase Company Profile & Funding
PharmAthene, Inc., a biodefense company, develops medical countermeasures to prevent and treat morbidity and mortality associated with the use of biological and chemical weapons in the …See details»
Neuraxpharm and Pharmathen enter into strategic co …
Dec 12, 2024 Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, …See details»
Pharmathene Company Profile 2024: Valuation, Investors
Information on acquisition, funding, investors, and executives for Pharmathene. Use the PitchBook Platform to explore the full profile.See details»
Contact - Pharmathen
Pharmathen International SA. 4 Dervenakion Street 15351 Pallini, Attica Greece T: +30 210 6604 300 F: +30 210 6666 749 info@pharmathen.com General Commercial Registry (GEMI) No: …See details»
Pharmathen - Overview, News & Similar companies | ZoomInfo.com
CVC Credit supports acquisition of Pharmathen by Partners Group CVC Credit supports acquisition of Pharmathen by Partners Group Submitted 25/01/2022 - 10:05am CVC Credit …See details»